MARKET

EBS

EBS

Emergent Bio
NYSE

Real-time Quotes | Nasdaq Last Sale

53.99
-0.99
-1.80%
After Hours: 53.99 0 0.00% 18:55 12/09 EST
OPEN
54.90
PREV CLOSE
54.98
HIGH
55.42
LOW
53.73
VOLUME
231.78K
TURNOVER
--
52 WEEK HIGH
69.86
52 WEEK LOW
39.11
MARKET CAP
2.79B
P/E (TTM)
-3528.7582
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EBS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EBS News

  • Emergent Biosolutions (EBS) Down 4.4% Since Last Earnings Report: Can It Rebound?
  • Zacks.3d ago
  • BioCorRx up 8% on encouraging data on opioid overdose candidate
  • Seeking Alpha - Article.6d ago
  • Emergent BioSolutions Highlights Presentation Of Immunogenicity Results From Phase 2 Study Of Investigational Chikungunya VLP Vaccine Candidate
  • Benzinga.11/22 13:23
  • Emergent BioSolutions Presents Positive Immunogenicity Results From Phase 2 Study of Its Investigational Chikungunya VLP Vaccine Candidate
  • GlobeNewswire.11/22 13:19

More

Industry

Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
+0.23%

Hot Stocks

Name
Price
%Change

About EBS

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
More

Webull offers Emergent Biosolutions Inc (EBS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.